Urinary proteomics in kidney and cardiovascular disease
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Video |
| Language: | English |
| Published: |
London :
Henry Stewart Talks,
2013.
|
| Series: | Henry Stewart talks. Biomedical & life sciences collection. Clinical proteomics.
Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease. |
| Subjects: | |
| Online Access: | https://hstalks.com/bs/2678/ Series (Clinical proteomics) Series (Kidney in health and disease) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Add Tag
Table of Contents:
- Contents: Omics technologies
- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS)
- Clinical proteomics
- Precision as a function of no. of markers
- Human urinary LMW proteome database
- Requirements for biomarker selection
- How to identify valid proteomic biomarkers
- Effect size estimation and the number of samples
- Erroneous biomarkers
- Classification using different sizes of training sets
- Classification errors
- CKD biomarkers
- Biomarker validation
- Pathophysiological suggestions
- Selected urinary peptides and CKD staging
- Multicentric European PRIORITY trial
- Proteomics of coronary artery disease and of diabetic nephropathy.
Urinary proteomics in kidney and cardiovascular disease